KR100699287B1 - 콜레스테롤 강하제의 용도 - Google Patents

콜레스테롤 강하제의 용도 Download PDF

Info

Publication number
KR100699287B1
KR100699287B1 KR1020017009822A KR20017009822A KR100699287B1 KR 100699287 B1 KR100699287 B1 KR 100699287B1 KR 1020017009822 A KR1020017009822 A KR 1020017009822A KR 20017009822 A KR20017009822 A KR 20017009822A KR 100699287 B1 KR100699287 B1 KR 100699287B1
Authority
KR
South Korea
Prior art keywords
per day
drug
levels
administering
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020017009822A
Other languages
English (en)
Korean (ko)
Other versions
KR20010089631A (ko
Inventor
라자알리
Original Assignee
아스트라제네카 아베
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26315084&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR100699287(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9902590.0A external-priority patent/GB9902590D0/en
Priority claimed from GBGB9921062.7A external-priority patent/GB9921062D0/en
Application filed by 아스트라제네카 아베 filed Critical 아스트라제네카 아베
Publication of KR20010089631A publication Critical patent/KR20010089631A/ko
Application granted granted Critical
Publication of KR100699287B1 publication Critical patent/KR100699287B1/ko
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020017009822A 1999-02-06 2000-02-01 콜레스테롤 강하제의 용도 Ceased KR100699287B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9902590.0A GB9902590D0 (en) 1999-02-06 1999-02-06 Use of cholesterol-lowering agent
GB9902590.0 1999-02-06
GBGB9921062.7A GB9921062D0 (en) 1999-09-08 1999-09-08 Use of cholestrol-lowering agent
GB9921062.7 1999-09-08

Publications (2)

Publication Number Publication Date
KR20010089631A KR20010089631A (ko) 2001-10-06
KR100699287B1 true KR100699287B1 (ko) 2007-03-26

Family

ID=26315084

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020017009822A Ceased KR100699287B1 (ko) 1999-02-06 2000-02-01 콜레스테롤 강하제의 용도

Country Status (22)

Country Link
EP (1) EP1150679A1 (https=)
JP (2) JP2002536333A (https=)
KR (1) KR100699287B1 (https=)
CN (1) CN1347320A (https=)
AR (1) AR022462A1 (https=)
AU (1) AU769897B2 (https=)
BR (1) BR0007991A (https=)
CA (1) CA2358641A1 (https=)
CZ (1) CZ20012631A3 (https=)
EE (1) EE04659B1 (https=)
HK (1) HK1040924A1 (https=)
HU (1) HUP0105019A3 (https=)
ID (1) ID30131A (https=)
IL (1) IL144662A0 (https=)
IS (1) IS5996A (https=)
MY (1) MY136382A (https=)
NO (1) NO319827B1 (https=)
NZ (1) NZ512681A (https=)
PL (1) PL349137A1 (https=)
SK (1) SK11112001A3 (https=)
TR (1) TR200102236T2 (https=)
WO (1) WO2000045819A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0001621D0 (en) * 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
GB0003305D0 (en) 2000-02-15 2000-04-05 Zeneca Ltd Pyrimidine derivatives
SE0103509D0 (sv) * 2001-10-19 2001-10-19 Astrazeneca Ab Rosuvastatin in pre demented states
GB0322552D0 (en) 2003-09-26 2003-10-29 Astrazeneca Uk Ltd Therapeutic treatment
WO2007142581A1 (en) * 2006-06-07 2007-12-13 Astrazeneca Ab Combination product for the treatment or prevention of dyslipidaemia
CA2689523A1 (en) 2007-06-20 2008-12-24 Merck Sharp & Dohme Corp. Cetp inhibitors derived from benzoxazole arylamides
EP2166847B1 (en) 2007-06-20 2014-11-19 Merck Sharp & Dohme Corp. Cetp inhibitors derived from benzoxazole arylamides
WO2008156715A1 (en) 2007-06-20 2008-12-24 Merck & Co., Inc. Cetp inhibitors derived from benzoxazole arylamides
EP2216095A1 (en) * 2009-01-27 2010-08-11 Koninklijke Philips Electronics N.V. Microfluidic device for full blood count

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0521471A1 (en) * 1991-07-01 1993-01-07 Shionogi Seiyaku Kabushiki Kaisha Pyrimidine derivatives as HMG-CoA reductase inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260446A (en) * 1989-12-22 1993-11-09 Basf Aktiengesellschaft Aminothiazoles

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0521471A1 (en) * 1991-07-01 1993-01-07 Shionogi Seiyaku Kabushiki Kaisha Pyrimidine derivatives as HMG-CoA reductase inhibitors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
1020017009822 - 683053

Also Published As

Publication number Publication date
KR20010089631A (ko) 2001-10-06
AR022462A1 (es) 2002-09-04
AU2305100A (en) 2000-08-25
NO20013810D0 (no) 2001-08-03
MY136382A (en) 2008-09-30
NO20013810L (no) 2001-10-03
EE200100404A (et) 2002-10-15
ID30131A (id) 2001-11-08
HUP0105019A2 (hu) 2002-05-29
WO2000045819A1 (en) 2000-08-10
IL144662A0 (en) 2002-05-23
CA2358641A1 (en) 2000-08-10
NZ512681A (en) 2003-12-19
AU769897B2 (en) 2004-02-05
CN1347320A (zh) 2002-05-01
JP2011137023A (ja) 2011-07-14
HUP0105019A3 (en) 2003-02-28
HK1040924A1 (zh) 2002-06-28
EE04659B1 (et) 2006-08-15
SK11112001A3 (sk) 2002-02-05
TR200102236T2 (tr) 2001-12-21
BR0007991A (pt) 2001-11-06
CZ20012631A3 (cs) 2001-10-17
JP2002536333A (ja) 2002-10-29
EP1150679A1 (en) 2001-11-07
PL349137A1 (en) 2002-07-01
NO319827B1 (no) 2005-09-19
IS5996A (is) 2001-07-10

Similar Documents

Publication Publication Date Title
KR100815042B1 (ko) 이형접합성 가족성 고콜레스테롤혈증 치료에 있어서로수바스타틴(ｚｄ－４５２２)의 용도
US6369103B1 (en) Method for preventing or reducing risk of onset of cardiovascular events employing an HMG CoA reductase inhibitor
US6982157B1 (en) Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methylsulfonyl)amino] pyrimidin-5-yl] (3r,5s) -3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3A4
JP2011137023A (ja) コレステロール低下薬の使用
Schug et al. Formulation-dependent food effects demonstrated for nifedipine modified-release preparations marketed in the European Union
JP2006520810A (ja) Ｓ−［２−（［［１−（２−エチルブチル）シクロヘキシル］カルボニル］アミノ）フェニル］２−メチルプロパンチオエートの経口吸収性を増加させる方法
EP1272219B1 (en) New combination of a betablocker and a cholesterol-lowering agent
KR20080081358A (ko) Ｈｉｖ 인테그라제 억제제의 약동학을 개선하기 위한 방법
US20070197602A1 (en) Combined pharmaceutical composition
MXPA01007294A (es) Uso de un agente que reduce colesterol
SK11092001A3 (sk) Kombinácia vzájomne nereagujúcich liečiv obsahujúca inhibítor hmg-coa reduktázy a inhibítor, induktor alebo substrát p450 izoenzýmu 3a4
TW202517250A (zh) Ｌｐ（ａ）干擾劑化合物之治療用途及劑量
CN100560075C (zh) 调节脂类代谢的药物
HU226062B1 (en) Drug combinations comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl-(methylsulfonyl)-amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4
HK1051325B (en) New combination of a betablocker and a cholesterol-lowering agent

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20010803

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20050131

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20060627

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20070115

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20070319

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20070320

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20100122

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20100122

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20110225

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20110225

Start annual number: 5

End annual number: 5

FPAY Annual fee payment

Payment date: 20120228

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20120228

Start annual number: 6

End annual number: 6

FPAY Annual fee payment

Payment date: 20130221

Year of fee payment: 7

PR1001 Payment of annual fee

Payment date: 20130221

Start annual number: 7

End annual number: 7

J204 Request for invalidation trial [patent]
PJ0204 Invalidation trial for patent

Patent event date: 20130524

Comment text: Request for Trial

Patent event code: PJ02042R01D

Patent event date: 20070319

Comment text: Registration of Establishment

Patent event code: PJ02041E01I

Appeal kind category: Invalidation

Request date: 20130524

Decision date: 20141119

Appeal identifier: 2013100001350

J204 Request for invalidation trial [patent]
PJ0204 Invalidation trial for patent

Patent event date: 20130627

Comment text: Request for Trial

Patent event code: PJ02042R01D

Patent event date: 20070319

Comment text: Registration of Establishment

Patent event code: PJ02041E01I

Appeal kind category: Invalidation

Request date: 20130627

Decision date: 20141119

Appeal identifier: 2013100001684

J204 Request for invalidation trial [patent]
PJ0204 Invalidation trial for patent

Patent event date: 20130731

Comment text: Request for Trial

Patent event code: PJ02042R01D

Patent event date: 20070319

Comment text: Registration of Establishment

Patent event code: PJ02041E01I

Appeal kind category: Invalidation

Request date: 20130731

Decision date: 20141119

Appeal identifier: 2013100002023

J204 Request for invalidation trial [patent]
PJ0204 Invalidation trial for patent

Patent event date: 20131129

Comment text: Request for Trial

Patent event code: PJ02042R01D

Patent event date: 20070319

Comment text: Registration of Establishment

Patent event code: PJ02041E01I

Appeal kind category: Invalidation

Request date: 20131129

Decision date: 20141119

Appeal identifier: 2013100003150

FPAY Annual fee payment

Payment date: 20140221

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20140221

Start annual number: 8

End annual number: 8

J204 Request for invalidation trial [patent]
PJ0204 Invalidation trial for patent

Patent event date: 20140410

Comment text: Request for Trial

Patent event code: PJ02042R01D

Patent event date: 20070319

Comment text: Registration of Establishment

Patent event code: PJ02041E01I

Appeal kind category: Invalidation

Request date: 20140410

Decision date: 20141119

Appeal identifier: 2014100000877

J301 Trial decision

Free format text: TRIAL DECISION FOR INVALIDATION REQUESTED 20131129

Effective date: 20141119

Free format text: TRIAL DECISION FOR INVALIDATION REQUESTED 20130524

Effective date: 20141119

Free format text: TRIAL DECISION FOR INVALIDATION REQUESTED 20130731

Effective date: 20141119

Free format text: TRIAL DECISION FOR INVALIDATION REQUESTED 20130627

Effective date: 20141119

Free format text: TRIAL NUMBER: 2013100001350; TRIAL DECISION FOR INVALIDATION REQUESTED 20130524

Effective date: 20141119

Free format text: TRIAL NUMBER: 2013100001684; TRIAL DECISION FOR INVALIDATION REQUESTED 20130627

Effective date: 20141119

Free format text: TRIAL NUMBER: 2013100002023; TRIAL DECISION FOR INVALIDATION REQUESTED 20130731

Effective date: 20141119

Free format text: TRIAL NUMBER: 2013100003150; TRIAL DECISION FOR INVALIDATION REQUESTED 20131129

Effective date: 20141119

Free format text: TRIAL NUMBER: 2014100000877; TRIAL DECISION FOR INVALIDATION REQUESTED 20140410

Effective date: 20141119

PJ1301 Trial decision

Appeal kind category: Invalidation

Request date: 20140410

Decision date: 20141119

Appeal identifier: 2014100000877

Appeal kind category: Invalidation

Request date: 20131129

Decision date: 20141119

Appeal identifier: 2013100003150

Appeal kind category: Invalidation

Request date: 20130731

Decision date: 20141119

Appeal identifier: 2013100002023

Appeal kind category: Invalidation

Request date: 20130627

Decision date: 20141119

Appeal identifier: 2013100001684

Patent event code: PJ13011S05D

Patent event date: 20141119

Comment text: Trial Decision on Invalidation (Patent, Utility Model, Industrial Design)

Appeal kind category: Invalidation

Request date: 20130524

Decision date: 20141119

Appeal identifier: 2013100001350

EXTG Ip right invalidated
PC2102 Extinguishment

Termination category: Others

Termination date: 20150508

Termination category: Others

Termination date: 20150204